. Addition results are shown here. In EMSA, pr1.2, pr5, pr6 and pr7 showed no bands (a). In reporter assay, subregions CR2.b, 2.c and 2.e did not allow GFP expression in developing chick neural tube (b). In gene knockdown assay, two sets of shRNA targeting each of Nkx6.1 and Phox2b were tested. Results of one set of constructs are shown in Fig. 2 , and the 2 nd set of constructs are shown here (c). NE, nuclear extract; DRG, dorsal root ganglion; D, dorsal; V, ventral. Scale bars = 50μm. Figure S3 . CR2 activity is found mainly in ventral spinal cord at E11.5. Staining with domain specific markers was performed to determine the identity of CR2-GFP+ cells at E11.5, including dp3~5 marker Ascl1 (a), dI1~3, 5 and V0 marker Brn3a (b), dI4 and dI6~V1 marker Pax2 (c), dI3 and MN marker Isl1 (d). GFP was found mainly in the ventral ventricular zone (pV0~3, pMN) and ventral marginal zone. Some GFP+ cells were also found in the dorsal marginal zone. VZ, ventricular zone; MZ, marginal zone; RP, roof plate; FP, floor plate; dp, dorsal interneuron progenitor layer; dI, dorsal interneuron layer; pV, ventral interneuron progenitor layer; V, ventral interneuron layer; pMN, motorneuron progenitor layer; MN motorneuron layer. Scale bars = 100μm. Figure S4 . Comparison of GFP expression in the transgenic mice with or without antibody retrieval. GFP expression in transgenic spinal cord at various developmental stages, e.g., E12.5 (a-b), E15.5 (c-d), P1 (e-f), and P7 (g-h) were examined by direct observation of GFP fluorescence (a, c, e, g) and with anti-GFP antibody staining (b, d, f, h). In all four stages, antibody staining either enhanced the GFP signal or revealed more cells have or had GFP expression. Arrows indicate cells only visualized in samples with anti-GFP staining. VZ, ventricular zone; MZ, margin zone. Scale bars = 100 μm. Figure S5 . CR2 activity is preferentially in interneuron progenitor domains but not motoneuron domain. Cross sections of transgenic spinal cord at E12.5, E15.5 and P1 were stained with domainspecific markers Brn3a (a-c), Pax2 (d-i) (interneuron) and Isl1 (k-m) (interneuron and motoneuron). Colabeled GFP+ cells (arrows) were found in all Brn3a+ domains, e.g., the region adjacent to the ventricular zone and the dorsal interneuron layers 1-3 and 5 (dI1-3, dI5) (dashed oval circles in a-c). Co-labeled GFP+ cells were also found in all Pax2+ domains including the dorsal interneuron layer 4, 6 (dI4, dI6), the ventral interneuron layer 0-1 (V0-1) (dashed circles/ovals in d-i) and Isl1+ dI3 domain (dashed ovals in k-m). No Isl1+/GFP+ cells were found in the motoneuron domain (MN) (solid ovals in k-m). Boxed regions are shown in higher magnification with arrows indicating co-labeled cells. Histogram shows the quantification of Brn3a+/GFP+, Pax2+/GFP+ and Isl1+/GFP+ cells (j, n). Less than 0.5% co-labeled cells were found in MN layer at E12.5 and 0% at E15.5 and P1 (n). Schematic of the distribution of Brn3a+ (orange), Pax2+ (purple) and Isl1+ (blue) cells at E15.5 (o). Green shaded area indicates the expression pattern of GFP. D, dorsal; V, ventral. Scale bars = 100 µm; n ≥ 3. Figure S6 . A small portion of CR2-GFP+ cells are located in the V0-2 domains of the developing spinal cord. Cross sections of transgenic spinal cord at E15.5 and P1 were stained with domain specific markers Evx1, En1, Chx10 and Gata2 (a-d). The expression pattern of the four markers is shown in schematic diagrams (e, with the dotted rectangle areas shown in (a-d)). A histogram of the marker+/GFP+ cells shows that about 3% of GFP+ cells locate in V0 at E15.5 and about 1% at P1, and less than 1% of GFP+ cells locate in V1 or V2 at E15.5 and P1 (f). Scale bar = 100 μm. Figure S7 . A small portion of CR2-GFP+ cells express S100b, GFAP and Olig2.
Cross sections of transgenic spinal cord at various developmental stages were stained with the astrocyte marker S100b (a, b), GFAP (d, e) and oligodendrocyte progenitor/oligodendrocyte marker Olig2 (g-h). S100b+/GFP+ (co-labeled) cells were found in both the grey matter and white matter at E15.5 (a, arrowheads). At P1, a few co-labeled cells can only be found in the white matter (b, arrowheads). Quantification shows the percentages of GFP+/S100b+ cells are small (c). GFAP+/GFP+ co-labeled cells were found in white matter at both E15.5 and P1 (d, e, arrowheads). Quantification shows the percentages of GFAP+/GFP+ cells increased from E15.5 to P1 (f). Olig2+/GFP+ cells were found at both E12.5 and E15.5, but only in the pMN domain where oligodendrocyte progenitor originates (g, h, arrowheads). No co-labeled cell can be found outside the ventricular zone. Quantification shows the percentage of colabeled cells is about 1% (i). Boxed regions are shown in higher magnification with arrowheads indicating co-labeled cells. D, dorsal; V, ventral. Scale bar = 100 µm. T-test: * p-value < 0.05, ** p-value < 0.01; n ≥ 3. F:CTGCTGCCCTTCTACTGAATCCCGTCGG CCTCTGAATGGAAG Atoh1 R:CTTCCATTCAGAGGCCGACGGGATTCA GTAGAAGGGCAGCAG * these two deletion constructs were generated to eliminate TFBSs for Gsx1 and Nkx6.1 on CR2.a. 
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AGCTTTTCCAAAAAGGAGACGCACTACCCCGACATTTACACTCTTGATGTAA ATGTCGGGGTAGTGCGTCTCCG Table S5 . qRT-PCR primers 
